Method for improving the half-life of soluble viral-specific ligands on mucosal membranes
US6365156B1 · kind B1 · utility
12Cited by
4References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 14, 2000 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | Apr 14, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods of increasing the half-life of a viral-specific ligand on a mucosal membrane by modifying the viral-specific ligand to bind the bacteria colonized on the mucosal membrane. The invention also provides a chimeric molecule comprising a viral-specific ligand and a bacterial-specific ligand.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.